T
Tracy L. Diamond
Researcher at Merck & Co.
Publications - 17
Citations - 1656
Tracy L. Diamond is an academic researcher from Merck & Co.. The author has contributed to research in topics: Integrase & Medicine. The author has an hindex of 9, co-authored 11 publications receiving 1554 citations. Previous affiliations of Tracy L. Diamond include United States Military Academy & University of Pennsylvania.
Papers
More filters
Journal ArticleDOI
Global analysis of host-pathogen interactions that regulate early stage HIV-1 replication
Renate König,Yingyao Zhou,Daniel Elleder,Tracy L. Diamond,Ghislain M. C. Bonamy,Jeffrey T. Irelan,Chih-yuan Chiang,Buu P. Tu,Paul D. De Jesus,Caroline E. Lilley,Shannon Seidel,Amanda M. Opaluch,Jeremy S. Caldwell,Matthew D. Weitzman,Kelli Kuhen,Sourav Bandyopadhyay,Trey Ideker,Anthony P. Orth,Loren Miraglia,Frederic D. Bushman,John A. T. Young,Sumit K. Chanda +21 more
TL;DR: A multiscale approach to assemble a host-pathogen biochemical network containing 213 confirmed host cellular factors and 11 HIV-1-encoded proteins has uncovered multiprotein virus-host interactions that likely act in concert to facilitate the early steps of HIV- 1 infection.
Journal ArticleDOI
Host Cell Factors in HIV Replication: Meta-Analysis of Genome-Wide Studies
Frederic D. Bushman,Nirav Malani,Jason D Fernandes,Jason D Fernandes,Iván D'Orso,Iván D'Orso,Gerard Cagney,Gerard Cagney,Gerard Cagney,Tracy L. Diamond,Honglin Zhou,Daria J. Hazuda,Amy S. Espeseth,Renate König,Sourav Bandyopadhyay,Trey Ideker,Stephen P. Goff,Nevan J. Krogan,Nevan J. Krogan,Alan D. Frankel,Alan D. Frankel,John A. T. Young,Sumit K. Chanda +22 more
TL;DR: An “encyclopedia” of all overlaps between studies yielded a more extensively corroborated set of host factors assisting HIV replication, and refined networks that specify cellular subsystems recruited by HIV to assist in replication are reported.
Journal ArticleDOI
Modulating target site selection during human immunodeficiency virus DNA integration in vitro with an engineered tethering factor.
TL;DR: Investigation of the use of artificial tethering interactions to constrain retroviral integration site selection in an in vitro model supports the idea that a direct interaction between LEDGF/p75 and IN can mediate targeting via a tethering mechanism, and provides proof of concept for the ideas that protein-protein interactions might be engineered to Constrain integration site Selection during human gene therapy.
Journal ArticleDOI
Design and Synthesis of Piperazine Sulfonamide Cores Leading to Highly Potent HIV-1 Protease Inhibitors
Christopher J. Bungard,Peter D. Williams,Jurgen Schulz,Catherine M. Wiscount,M. Katharine Holloway,Marie Loughran,Jesse J. Manikowski,Hua-Poo Su,David Jonathan Bennett,Lehua Chang,Xin-jie Chu,Alejandro Crespo,Michael P. Dwyer,Kartik M. Keertikar,Gregori J. Morriello,Andrew Stamford,Sherman T. Waddell,Bin Zhong,Bin Hu,Tao Ji,Tracy L. Diamond,Carolyn Bahnck-Teets,Steven S. Carroll,John F. Fay,Xu Min,William J. Morris,Jeanine E. Ballard,Michael D. Miller,John A. Mccauley +28 more
TL;DR: Using the HIV-1 protease binding mode of MK-8718 and PL-100 as inspiration, a novel aspartate binding bicyclic piperazine sulfonamide core was designed and synthesized and showed an 60-fold increase in enzyme binding affinity and a 10- fold increase in antiviral activity relative to MK- 8718.
Journal ArticleDOI
Role of metal ions in catalysis by HIV integrase analyzed using a quantitative PCR disintegration assay
TL;DR: A sensitive assay for DNA transesterification in which catalysis by human immunodeficiency virus-type 1 (HIV-1) integrase (IN) connects two DNA strands (disintegration reaction), allowing detection using quantitative PCR (qPCR).